Akero Therapeutics, Inc. (AKRO)
Delisted
9 Dec 2025
NASDAQ (NGS) NASDAQ (NGS) Primary $
54. 65
0
0%
After Hours
$
+15.35 +28.0878% 70. 00
4.47B Market Cap
- P/E Ratio
- Div Yield
11.61M Volume
-2.84 Eps
$ 54.65
Previous Close Investors:
Day Range
54.52 54.65
Year Range
21.34 58.4
Want to track AKRO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Akero Therapeutics, Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| VT Vincent Tortorella Point72 (DIFC) Ltd | 3,693 | $175,328 | $175,328 | - | - |
